Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity
Liqiu Jia(Fudan University), Yanmin Wan(Shanghai Medical College of Fudan University), Xiangxiang Tian(Fudan University), Shufeng Weng(Fudan University), Yifan Zhang(Anhui Agricultural University), Jing Wang(Flinders University), Fang Fang(Jinshan Hospital of Fudan University), Xuyang Wang(Fudan University), Jing Wu(Ningbo University), Ying Xu(Huadong Hospital), Wenhong Zhang(Fudan University), Zhaoqin Zhu(Shanghai Medical College of Fudan University), Wanhai Wang(First Affiliated Hospital of Zhengzhou University), Dongmei Yan(Chinese Center For Disease Control and Prevention), Chao Qiu(Fudan University)
Cited by 26
Related Papers
An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China
|Virology Journal|2010|473
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
|The Lancet|2013|359
Telomere Length and All-Cause Mortality: A Meta-analysis
|Ageing Research Reviews|2018|332
Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples
|Nature Biomedical Engineering|2022|332
Application of an oregano oil nanoemulsion to the control of foodborne bacteria on fresh lettuce
|Food Microbiology|2014|312